166
Views
18
CrossRef citations to date
0
Altmetric
Articles

CLINICAL FEATURES, TREATMENT RESPONSES, AND OUTCOME OF CHILDREN WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA

, MD, , MD, , MD, , MD & , MD
Pages 526-532 | Received 18 Feb 2008, Accepted 28 Apr 2009, Published online: 08 Oct 2009

REFERENCES

  • Nugent D J. Immune thrombocytopenic purpura of childhood. Hematol Am Soc Hematol Educ Program. 2006; 97–103
  • Rehman A. Acute immune thrombocytopenic purpura in children. Turk J Hematol. 2007; 24: 41–51
  • Cines D B, Blanchette V S. Immune thrombocytopenic purpura. N Engl J Med. 2002; 346: 995–1008
  • George J N, Woolf S H, Raskob G E, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3–40
  • Bolton-Maggs P H, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 1997; 350: 620–623
  • Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003; 25(Suppl 1)47–51
  • Buchanan G R. Bleeding signs in children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003; 25(Suppl 1)S42–S46
  • Lilleyman J S. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol. 1999; 105: 871–875
  • Kühne T. Idiopathic thrombocytopenic purpura in childhood: controversies and solutions. Pediatr Blood Cancer 2006; 47(Suppl 5)650–652
  • Buchanan G R, Adix L. Current challenges in the management of children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 2006; 47(Suppl 5)681–684
  • Imbach P. Development and research in idiopathic thrombocytopenic purpura: an inflammatory and autoimmune disorder. Pediatr Blood Cancer 2006; 47(Suppl 5)685–686
  • Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006; 133: 364–374
  • Ozsoylu S, Irken G, Karabent A. High-dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol 1989; 42: 431–435
  • Bolton-Maggs P H. Idiopathic thrombocytopenic purpura. Arch Dis Child 2000; 83: 220–222
  • Sutor A H, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 2001; 27: 253–267
  • Lilleyman J S. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 1994; 71: 251–253
  • Buchanan G R. The nontreatment of idiopathic thrombocytopaenic purpura. Eur J Pediatr. 1987; 146: 107–112
  • Chu Y W, Korb J, Sakamoto K M. Idiopathic thrombocytopaenic purpura. Pediatr Rev. 2000; 21: 95–103
  • Kühne T, Imbach P, Bolton-Maggs P H, Berchtold W, Blanchette V, Buchanan G R. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001; 358: 2122–2125
  • Tarantino M D, Bolton-Maggs P H. Update on the management of immune thrombocytopenic purpura in children. Curr Opin Hematol. 2007; 14: 526–534
  • Erduran E, Aslan Y, Gedik Y, Orhan F. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Turk J Pediatr. 2003; 45: 295–300
  • Koçak U, Aral Y Z, Kaya Z, Öztürk G, Gürsel T. Evaluation of clinical characteristics, diagnosis and management in childhood immune thrombocytopenic purpura: a single center's experience. Turk J Pediatr. 2007; 49: 250–255
  • Özsoylu S, Şaylı T R, Öztürk G. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol. 1993; 10: 317–321
  • Duru F, Fışgın T, Yaralı N, Kara A. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Pediatr Hematol Oncol. 2002; 19: 219–225
  • Albayrak D, İşlek I, Kalaycı A G, Gürses N. Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr. 1994; 125: 1004–1007
  • Yetgin S, Olcay L, Özsoylu S, Hiçsönmez G, Gürgey A, Tuncer A M. Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: follow-up from 1976 to 1996. Pediatr Hematol Oncol. 1997; 14: 399–412
  • Watts R G. Idiopathic Thrombocytopenic Purpura: A 10-year natural history study at the Childrens Hospital of Alabama. Clin Pediatr (Phil). 2004; 43: 691–702
  • Ahmed S, Siddiqui A K, Shahid R K, Kimpo M, Sison C P, Hoffman M A. Prognostic variables in newly diagnosed childhood immune thrombocytopenia. Am J Hematol. 2004; 77: 358–362
  • Blanchette V. Childhood chronic immune thrombocytopenic purpura (ITP). Blood Rev. 2002; 16: 23–26
  • Black C, Kaye J A, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003; 55: 107–111
  • Wang J D, Huang F L, Chen P Y, Wang T M, Chi C S, Chang T K. Acute immune thrombocytopenic purpura in infants: associated factors, clinical features, treatment and long-term outcome. Eur J Haematol. 2006; 77: 334–337

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.